JC: is Persistent Functional deficit following Mild Traumatic Brain Injury more common than we thought?
Is Persistent Functional deficit following Mild Traumatic Brain Injury more common than we thought?
Is Persistent Functional deficit following Mild Traumatic Brain Injury more common than we thought?
Research in cardiac arrest management has improved a lot in recent years. We are now seeing large randomised controlled trials looking at specific therapies in the management of these critically
Summer hols and quiet times for many of us at present, so apologies for lack of posts. There is always stuff going on in the background however, and several of
TBI: The Final Frontier… Read More »
This week we have a nice paper that highlights some of the ongoing thoughts and controversies about the use of calcium in major haemorrhage protocols. Hopefully you’ve already read Iain’s
More on Calcium and blood products in trauma. St Emlyn’s Read More »
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
Baricitinib for hospitalised COVID19 patients. St Emlyn’s Read More »
As several of you may know already, I’ve been spending a lot more time in the pre-hospital environment in the last few years. Despite many years working in busy emergency
The EXIT study extrication consensus statements. St Emlyn’s Read More »
As someone who works across both PEM and adult EM it’s interesting to reflect on how the workload varies. These days my adult work is heavily skewed to complex majors
The FORCE study: St Emlyn’s Read More »
The story of vitamin C in sepsis is fascinating. There was a great deal of controversy around what became known as the Marik protocol (after Prof. Paul Marik). The protocol
JC: Vitamin C and sepsis (again). St Emlyn’s Read More »